Urgent.News

What's breaking now, across thousands of outlets.

AI

Citrini Research is backing life sciences stocks after using Claude to design proteins

The firm designed 211 proteins with Claude for lab testing; 17 bound to scorpion toxins, but blocking effects are untested

Citrini Research is backing life sciences stocks after using Claude to design proteins

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

Read the original at qz.com →

More in AI

More from Tuesday 20 October →